Doctor profile · Federal record
Dr. Jonathan Delos Reyes, MD
Rheumatology Physician (CMS: Internal Medicine) · Denton, TX
- NPI 1780633255
- Accepts Medicare
- MIPS 76.0 / 100 · 2023
- 36 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4308 Mesa Dr, Suite A
Denton, TX 762073459
(940) 565-0600
fax (940) 565-1538
Credentials & registration
- NPI registered
- May 2006 — 20 yrs on file
- Profile last updated
- October 31, 2007
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Texas #K8112
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1780633255. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
15,250
Distinct HCPCS
8
Medicare allowed
$336,005
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 10,754 | 15 | $13 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 2,420 | 11 | $33 | |
J0897 |
Injection, denosumab, 1 mg | 1,200 | 11 | $22 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 456 | 182 | $122 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 186 | 18 | $69 | |
96413 |
Administration of chemotherapy into vein, 1 hour or less | 150 | 29 | $124 | |
96415 |
Administration of chemotherapy into vein, each additional hour | 61 | 11 | $27 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 23 | 23 | $214 |
In context: peer comparison
Among 1 peers in Denton Rheumatology Physician, average services per provider: 1,906. This provider delivers 8.0× the peer median.Open Payments
Industry payments received
All-time total
$2,277
Transactions
92
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 28 | $726.39 | |
| Ucb, INC. | 20 | $606.28 | |
| Ani Pharmaceuticals, INC. | 12 | $190.56 | |
| Amgen INC. | 9 | $186.21 | |
| Novartis Pharmaceuticals Corporation | 4 | $100.90 | |
| Radius Health, INC. | 4 | $75.63 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $64.37 | |
| Fresenius Kabi USA, LLC | 2 | $54.67 | |
| Lilly USA, LLC | 2 | $50.84 | |
| Aurinia Pharma U.S., INC. | 2 | $40.78 | |
| GlaxoSmithKline, LLC. | 2 | $37.16 | |
| Pfizer INC. | 1 | $24.78 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $24.57 | |
| Sandoz INC. | 1 | $24.41 | |
| Mallinckrodt Hospital Products INC. | 1 | $19.51 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,134
Patients
369
Total drug cost
$358,390
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 302 | 97 | $15,983 |
| Duloxetine Hcl | Generic | 143 | 48 | $2,789 |
| Prednisone | Generic | 133 | 56 | $1,103 |
| Hydroxychloroquine Sulfate | Generic | 129 | 43 | $11,921 |
| Meloxicam | Generic | 67 | 31 | $242 |
| Alendronate Sodium | Generic | 54 | 14 | $534 |
| Pregabalin | Generic | 52 | 17 | $1,017 |
| Folic Acid | Generic | 40 | 16 | $401 |
| Celecoxib | Generic | 37 | 11 | $1,149 |
| Gabapentin | Generic | 36 | 12 | $366 |
Frequently asked questions
What is Dr. Jonathan Delos Reyes's medical specialty?
Dr. Jonathan Delos Reyes practices Rheumatology Physician in Denton, TX.
Where does Dr. Jonathan Delos Reyes practice?
Dr. Jonathan Delos Reyes practices at 4308 Mesa Dr, Denton, TX 762073459. Office phone: 9405650600.
What is Dr. Jonathan Delos Reyes's NPI?
Dr. Jonathan Delos Reyes's National Provider Identifier (NPI) is 1780633255, issued by NPPES.
Does Dr. Jonathan Delos Reyes accept Medicare assignment?
Yes. Dr. Jonathan Delos Reyes accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Jonathan Delos Reyes commonly perform?
Top Medicare-reported procedures in 2023: Injection, golimumab, 1 mg, for intravenous use (HCPCS J1602); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745); Injection, denosumab, 1 mg (HCPCS J0897). Source: CMS Medicare Physician & Other Practitioners file.